Tislelizumab and Lenvatinib Show Efficacy in Advanced Rare Kidney Cancer
A phase 2 clinical trial shows that combining tislelizumab and lenvatinib produces high objective response rates in patients with advanced ...
A phase 2 clinical trial shows that combining tislelizumab and lenvatinib produces high objective response rates in patients with advanced ...
A multicenter phase 2 clinical trial in China found oral onradivir granules were well tolerated and achieved adult-equivalent exposure in ...
A phase 2 open-label trial evaluated the safety and exploratory efficacy of the repurposed leukemia drug bosutinib in patients with ...
A phase 2 trial found that adding immunotherapy to chemotherapy did not improve the primary efficacy endpoint in advanced ovarian ...
In a single-arm phase 2 trial of 39 women with HR+/HER2- advanced breast cancer, first-line oral culmerciclib plus an aromatase ...
A randomized phase 2 trial found 2-HOBA was safe and well tolerated in rheumatoid arthritis patients but did not significantly ...
A phase 2 trial reports that camrelizumab plus famitinib produced tumor shrinkage in 42.9 percent of patients with advanced pulmonary ...
A phase 2 randomized trial found favorable biological, clinical and exploratory survival signals from vitamin C in pre-cancer blood disorders, ...
In the ever-evolving landscape of pediatric medicine, the quest for safe and effective anesthetic protocols remains a critical priority. A ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.